Clinical Trial Update: Safety and Tolerability of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating safety and tolerability of SYNB1618 in healthy adults and adults with phenylketonuria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• SYNB1618 (SYNB1618)

Snippet

Sponsor: Synlogic | Conditions: Phenylketonuria, Healthy | Phase 1, Phase 2 | Status: COMPLETED